CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Immunological Bridging Study Assessing the Non-inferiority of a New Formulation of ETVAX®. A Prospective Double-blind, Randomized Study in Healthy Volunteers.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05178134
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:26.452910+00:00
Published At: 2025-08-19T00:00:00+00:00
Record Updated At: 2025-08-19
Results Posted At: 2025-08-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Healty Volunteers", "Preventable Disease, Vaccine"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-19"
protocolSection.identificationModule.nctId: "NCT05178134"
protocolSection.identificationModule.officialTitle: "A Phase 2 Immunological Bridging Study Assessing the Non-inferiority of a New Formulation of ETVAX\u00ae. A Prospective Double-blind, Randomized Study in Healthy Volunteers."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-08-19"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.